624 related articles for article (PubMed ID: 25242213)
1. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
Sun X; Hirota SA
Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
[TBL] [Abstract][Full Text] [Related]
2. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
3. The role of toxins in Clostridium difficile infection.
Chandrasekaran R; Lacy DB
FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
[TBL] [Abstract][Full Text] [Related]
4. Host recognition of Clostridium difficile and the innate immune response.
Cowardin CA; Petri WA
Anaerobe; 2014 Dec; 30():205-9. PubMed ID: 25223264
[TBL] [Abstract][Full Text] [Related]
5. Enterotoxic Clostridia:
Mileto S; Das A; Lyras D
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31124432
[No Abstract] [Full Text] [Related]
6. Recent insights into Clostridium difficile pathogenesis.
Peniche AG; Savidge TC; Dann SM
Curr Opin Infect Dis; 2013 Oct; 26(5):447-53. PubMed ID: 23982235
[TBL] [Abstract][Full Text] [Related]
7. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.
Shin JH; High KP; Warren CA
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):916-22. PubMed ID: 26809495
[TBL] [Abstract][Full Text] [Related]
8. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to Clostridium difficile infection.
Madan R; Petri WA
Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763
[TBL] [Abstract][Full Text] [Related]
10. ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.
Zackular JP; Knippel RJ; Lopez CA; Beavers WN; Maxwell CN; Chazin WJ; Skaar EP
mSphere; 2020 Mar; 5(2):. PubMed ID: 32161145
[No Abstract] [Full Text] [Related]
11. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
[TBL] [Abstract][Full Text] [Related]
12. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.
Cowardin CA; Buonomo EL; Saleh MM; Wilson MG; Burgess SL; Kuehne SA; Schwan C; Eichhoff AM; Koch-Nolte F; Lyras D; Aktories K; Minton NP; Petri WA
Nat Microbiol; 2016 Jul; 1(8):16108. PubMed ID: 27573114
[TBL] [Abstract][Full Text] [Related]
13. Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.
Johnston PF; Gerding DN; Knight KL
Infect Immun; 2014 Feb; 82(2):522-31. PubMed ID: 24478068
[TBL] [Abstract][Full Text] [Related]
14. Mouse relapse model of Clostridium difficile infection.
Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile toxins: mediators of inflammation.
Shen A
J Innate Immun; 2012; 4(2):149-58. PubMed ID: 22237401
[TBL] [Abstract][Full Text] [Related]
16. Cellular Uptake and Mode-of-Action of Clostridium difficile Toxins.
Papatheodorou P; Barth H; Minton N; Aktories K
Adv Exp Med Biol; 2018; 1050():77-96. PubMed ID: 29383665
[TBL] [Abstract][Full Text] [Related]
17. New perspectives in Clostridium difficile disease pathogenesis.
Monaghan TM
Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
[TBL] [Abstract][Full Text] [Related]
18. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
[TBL] [Abstract][Full Text] [Related]
19. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
[TBL] [Abstract][Full Text] [Related]
20. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
